CSBR:NASDAQ
Champions Oncology Inc
$4.82
arrow_downward
-0.41%(-0.020) 1D
Nov 10, 12:42:54 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
$4.82
High
$4.84
Low
$4.82
Mkt. cap
67.09M
Avg. vol.
9.19K
Volume
619.00
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
Open
$4.82
High
$4.84
Low
$4.82
Mkt. cap
67.09M
Avg. vol.
9.19K
Volume
619.00
52-wk high
$8.31
52-wk low
$4.63
EPS
-$0.08
Beta
0.47
Shares outstanding
13.92M
No. of employees
217
News stories
From web sources and news partners
The Motley Fool
·
29 minutes ago
Is the S&P 500 Heading for a Correction?
24/7 Wall St.
·
1 hour ago
Apple Turned $1,000 Into $13,805 in Ten Years, More Than Three Times What the S&P 500 Delivered
www.tmgm.com
·
1 hour ago
Can Dow Jones Futures Extend Gains as Inflation Data and Tech Earnings Come into Focus?
FXEmpire
·
1 hour ago
Nasdaq Index and S&P500: Hot CPI Reverses Monday’s Tech-Led Rally
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, United States
SectorHealth Care
Industry-
Websitechampionsoncology.com